Executive summary :Square Pharmaceuticals Ltd. was established as a partnership firm in 1958. In 1991 it was converted into a public limited company. Square Pharmaceuticals Limited is the largest pharmaceutical company in Bangladesh and it has been continuously in the 1st position among all national and multinational companies since 1985. Since 1987 Square has taken aggressive measures to explore new countries as potential export market. More & more countries are getting confidence in Square’s
Premium Pharmacology Quality control Quality assurance
Vaccine and Medicine Word Count- (3‚050) Executive Summary GlaxoSmithKline is one of the major pharmaceutical companies in United Kingdom that continues to traverse the competitive and challenging pharmaceutical industry. This report gives insight on the analysis of the strategies used by GlaxoSmithKline (vaccines and medicine business unit) to be able to sustain its performance in the pharmaceutical industry. This report applies PESTLE model‚ Porter’s five-force model‚ and Value chain analysis
Premium Pharmaceutical industry Strategic management Marketing
Health Care Reform Project YOURNAME CLASS DATE PRESENTED TO Health Care Reform Project Prescription drugs are one of the main increasing costs in health care. It has an impact on the population that could not afford prescription drugs‚ including brand name. The use of generic and OTC (over-the-counter) drugs gave the underprivileged groups in America a better chance for purchase. People believe that the generic form of the drugs do not have the same effect that brand name
Premium Pharmacology Medicine Food and Drug Administration
&company Question: To continue generating the returns enjoyed by the industry over the past decade‚ pharmaceutical companies would be forced to rethink how they identify and exploit opportunities to gain a competitive edge in an increasingly complex market ? In my opinion if a Pharmaceutical company aims to continue generating the returns and gain competitive edge ‚ should conduct Pharmaceutical Industry Analysis which will help to find out opportunities and then should try to match them with
Premium Pharmacology Strategic management Marketing
1.1 Introduction: 1.2 Literature review: 1.3 Objective: Broad Objective: To describe the marketing pattern of pharmaceuticals industry in Bangladesh by analyzing the marketing mix of Biopharma Laboratories Ltd. Short/Specific Objectives: The report contains the following specific objectives- To describe all types of products those are produced by Biopharma Laboratories Ltd. Describing the pricing procedure and price list of Biopharma Laboratories Ltd. To describe all types
Premium Marketing Pharmaceutical industry
continues to devaluate against the dollar it could affect the Indonesian pharmaceutical market in US dollar terms‚ notes a new report from Espicom. Enjoying this article? Have the leading Biopharma news & analysis delivered daily on email by signing up for our FREE email newsletter here. Legally‚ Indonesia remained on the US Trade Represenative’s Special 301 Priority Watch List in 2011‚ due to the prevalence of counterfeit pharmaceuticals. Demographically‚ the population will be the third largest in the
Premium Pharmaceutical industry Indonesia Pharmacology
19 1) Executive Summary Indian Pharmaceutical Industry The Indian Pharmaceutical Industry today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology India‚ which is the 3rd Largest Producer of Pharmaceuticals Across the World- is already a US$ 8.2 Billion pharmaceutical market. The Indian pharmaceutical industry is further expected to grow by 10% in the year 2010. It ranks
Premium Financial ratios Inventory Generic drug
Five Forces of the global Pharmaceutical industry THE CANCER MARKET Cancer is a disease which has a high disease burden throughout the world and whose treatment is notoriously difficult. The market for anti-cancer drugs can be described as being in the “growth phase” of the industry cycle. Threat of entry - MEDIUM Based on previous traditional “synthetic drug development model” for cancer‚ threat of entry has been low based on high fixed costs required for the arduous processes of drug discovery
Premium Pharmacology Pharmaceutical industry
ABSTRACT The last decade has seen significant consolidation in the Indian Pharmaceutical Industry driven by acquisition of large Indian generic manufacturers by top global pharmaceutical firms (such as Piramal’s and Ranbaxy’s takeover by Abbott and Daiichi Sankyo respectively). The Indian pharmaceutical industry is worth $4.5bn today and is growing at 15%+.It presents several attractive opportunities for global pharmaceutical companies. First‚ it gives them access to the developing world. Given the
Premium Pharmaceutical industry Generic drug Pharmacology
went wrong? What are the main external and internal factors that encouraged the GSK bribery scandal in China? Which‚ in your opinion‚ are more important? Explain your position. According to Quelch & Rodriguez (2013)‚ GlaxoSmithKline (GSK) is a pharmaceutical company that started off as an import-export business in New Zealand and has expanded into a worldwide firm with offices in United Kingdom‚ India‚ South America‚ China‚ Malaysia‚ and Greece (Quelch & Rodriguez‚ 2013). DRS explains one of the challenging
Premium Foreign Corrupt Practices Act United States Bribery